BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19252089)

  • 21. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.
    Shakur Y; Fong M; Hensley J; Cone J; Movsesian MA; Kambayashi J; Yoshitake M; Liu Y
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):417-27. PubMed ID: 12652111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytes.
    Knebel SM; Elrick MM; Bowles EA; Zdanovec AK; Stephenson AH; Ellsworth ML; Sprague RS
    Exp Biol Med (Maywood); 2013 Sep; 238(9):1069-74. PubMed ID: 23986226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct patterns of constitutive phosphodiesterase activity in mouse sinoatrial node and atrial myocardium.
    Hua R; Adamczyk A; Robbins C; Ray G; Rose RA
    PLoS One; 2012; 7(10):e47652. PubMed ID: 23077656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling.
    Phillips PG; Long L; Wilkins MR; Morrell NW
    Am J Physiol Lung Cell Mol Physiol; 2005 Jan; 288(1):L103-15. PubMed ID: 15377497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty.
    Zhao H; Quilley J; Montrose DC; Rajagopalan S; Guan Q; Smith CJ
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2973-81. PubMed ID: 17293498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells.
    Côté M; Payet MD; Rousseau E; Guillon G; Gallo-Payet N
    Endocrinology; 1999 Aug; 140(8):3594-601. PubMed ID: 10433216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels.
    Rochais F; Vandecasteele G; Lefebvre F; Lugnier C; Lum H; Mazet JL; Cooper DM; Fischmeister R
    J Biol Chem; 2004 Dec; 279(50):52095-105. PubMed ID: 15466415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDE3 and PDE4 isozyme-selective inhibitors are both required for synergistic activation of brown adipose tissue.
    Kraynik SM; Miyaoka RS; Beavo JA
    Mol Pharmacol; 2013 Jun; 83(6):1155-65. PubMed ID: 23493317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
    Chini CC; Grande JP; Chini EN; Dousa TP
    J Biol Chem; 1997 Apr; 272(15):9854-9. PubMed ID: 9092521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
    Tilley DG; Maurice DH
    Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
    Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
    FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of cell confluence on the cAMP signalling pathway in vascular smooth muscle cells.
    Belacel-Ouari M; Zhang L; Hubert F; Assaly R; Gerbier R; Jockers R; Dauphin F; Lechêne P; Fischmeister R; Manoury B; Leblais V
    Cell Signal; 2017 Jul; 35():118-128. PubMed ID: 28389413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal Spontaneous Firing of Rabbit Sinoatrial Node Cells Is Regulated by Dual Activation of PDEs (Phosphodiesterases) 3 and 4.
    Vinogradova TM; Sirenko S; Lukyanenko YO; Yang D; Tarasov KV; Lyashkov AE; Varghese NJ; Li Y; Chakir K; Ziman B; Lakatta EG
    Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e005896. PubMed ID: 29880528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.
    Favot L; Keravis T; Holl V; Le Bec A; Lugnier C
    Thromb Haemost; 2003 Aug; 90(2):334-43. PubMed ID: 12888882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase.
    Hanson MS; Stephenson AH; Bowles EA; Sprague RS
    Exp Biol Med (Maywood); 2010 Feb; 235(2):256-62. PubMed ID: 20404042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.